If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hidefumi Kasai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Pharmacokinetics Medicine & Life Sciences
Linezolid Medicine & Life Sciences
Population Medicine & Life Sciences
Kidney Medicine & Life Sciences
Healthy Volunteers Medicine & Life Sciences
Mutagenesis Chemical Compounds
zoledronic acid Medicine & Life Sciences
eribulin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 113 Citations
  • 6 h-Index
  • 22 Article
  • 1 Editorial
  • 1 Letter
  • 1 Short survey

Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms

Yamaguchi, D., Tsuji, Y., Sonoda, M., Shin, K., Kito, H., Ogami, C., Kasai, H., To, H. & Kamimura, H., 2019 Jun 1, In : European Journal of Drug Metabolism and Pharmacokinetics. 44, 3, p. 329-338 10 p.

Research output: Contribution to journalArticle

Lithium Carbonate
2 Citations (Scopus)

An analysis on distribution and inter-relationships of biomarkers under rivaroxaban in Japanese patients with non-valvular atrial fibrillation (CVI ARO 1)

Suzuki, S., Yamashita, T., Kasai, H., Otsuka, T. & Sagara, K., 2018 Aug, In : Drug Metabolism And Pharmacokinetics. 33, 4, p. 188-193 6 p.

Research output: Contribution to journalArticle

Atrial Fibrillation
Prothrombin Time
6 Citations (Scopus)

Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker

Mori, Y., Kasai, H., Ose, A., Serada, M., Ishiguro, M., Shiraki, M. & Tanigawara, Y., 2018 Feb 8, (Accepted/In press) In : Osteoporosis International. p. 1-9 9 p.

Research output: Contribution to journalArticle

zoledronic acid
Bone Resorption
Bone Density
Theoretical Models

Pharmacodynamic analysis of eribulin safety in breast cancer patients using real-world postmarketing surveillance data

Kawamura, T., Kasai, H., Fermanelli, V., Takahashi, T., Sakata, Y., Matsuoka, T., Ishii, M. & Tanigawara, Y., 2018 Jan 1, (Accepted/In press) In : Cancer Science.

Research output: Contribution to journalArticle

Breast Neoplasms
1 Citation (Scopus)

Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function

Kasai, H., Tsuji, Y., hiraki, Y., Tsuruyama, M., To, H. & Yamamoto, Y., 2018 Apr, In : Journal of Infection and Chemotherapy. 24, 4, p. 284-291 8 p.

Research output: Contribution to journalArticle

Cystatin C